Journal article · 2024 · Open access

Prospects and challenges of targeted extracellular vesicles drug delivery for cancer treatment

Fatemeh Maher, Ali Samadi, Peyman Asadi, Isabella Jodoin

Extracellular Vesicle, 4, 100059 · Published 1 December 2024 · DOI 10.1016/j.vesic.2024.100059

Read the free full textCite this paper

In brief

“Prospects and challenges of targeted extracellular vesicles drug delivery for cancer treatment” is a 2024 journal article by Fatemeh Maher and 3 co-authors, published in Extracellular Vesicle. OpenAlex counts 8 citations as of 15 November 2026, which puts it in the top 4% of works published in 2024 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Extracellular Vesicle.

Citations
8
Most cited in
2025 (4)
Field-weighted impact
0.87
References
174
Authors
4

Abstract

Extracellular vesicles (EVs) have the ability to alter the phenotypes and functions of other cells as well as reflect the state of the cell from whence they originated. Extracellular vesicles, or EVs, are membrane-bound nanostructures released into the extracellular environment. Under both normal and pathological circumstances, they are widely discharged from cells and display a variety of sizes, contents, and surface marks. These EVs are abundant in human serum, yet it might be difficult to separate them from non-EV lipid particles and serum proteins . These vesicles influence several physiological and pathological processes , including those that occur in the tumor microenvironment (TME), by transporting different cellular constituents such as proteins, mRNAs, miRNAs , DNA, and lipids across distances. EVs are potential possibilities for therapeutic agents, medication delivery methods, and disease biomarkers due to their crucial functions in cellular communication. EV detection has the potential to serve as a diagnostic biomarker and can facilitate early identification, particularly in the context of cancer diagnosis. Furthermore, EV subtypes may be clinically significant as different subtypes are emerging as targeted medication delivery methods. There is still a need for non-invasive biomarkers to track biological processes for treatment and diagnosis. In the future, utilizing EVs' distinct composition may open up new possibilities for enhanced diagnosis and treatment.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Maher, F., Samadi, A., Asadi, P., & Jodoin, I. (2024). Prospects and challenges of targeted extracellular vesicles drug delivery for cancer treatment. Extracellular Vesicle, 4, 100059. https://doi.org/10.1016/j.vesic.2024.100059

MLA 9

Maher, Fatemeh, et al. “Prospects and challenges of targeted extracellular vesicles drug delivery for cancer treatment.” Extracellular Vesicle, vol. 4, 2024, p. 100059. https://doi.org/10.1016/j.vesic.2024.100059.

Chicago

Maher, Fatemeh, Ali Samadi, Peyman Asadi, and Isabella Jodoin. 2024. “Prospects and challenges of targeted extracellular vesicles drug delivery for cancer treatment.” Extracellular Vesicle 4: 100059. https://doi.org/10.1016/j.vesic.2024.100059.

Harvard

Maher, F. et al. (2024) ‘Prospects and challenges of targeted extracellular vesicles drug delivery for cancer treatment’, Extracellular Vesicle, 4, p. 100059. doi:10.1016/j.vesic.2024.100059.

IEEE

F. Maher, A. Samadi, P. Asadi, and I. Jodoin, “Prospects and challenges of targeted extracellular vesicles drug delivery for cancer treatment,” Extracellular Vesicle, vol. 4, p. 100059, 2024, doi: 10.1016/j.vesic.2024.100059.

BibTeX

@article{maher2024prospects,
  title     = {{Prospects and challenges of targeted extracellular vesicles drug delivery for cancer treatment}},
  author    = {Maher, Fatemeh and Samadi, Ali and Asadi, Peyman and Jodoin, Isabella},
  journal   = {Extracellular Vesicle},
  year      = {2024},
  volume    = {4},
  pages     = {100059},
  doi       = {10.1016/j.vesic.2024.100059},
  url       = {https://doi.org/10.1016/j.vesic.2024.100059}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease

  • extracellular vesicles
  • targeted drug delivery
  • cancer therapy
  • tumor microenvironment
  • tumor markers
  • non-invasive biomarkers
  • EV cargo
  • cell-to-cell communication

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Maher, F., Samadi, A., Asadi, P., & Jodoin, I. (2024). Prospects and challenges of targeted extracellular vesicles drug delivery for cancer treatment. Extracellular Vesicle, 4, 100059. https://doi.org/10.1016/j.vesic.2024.100059

How many times has this paper been cited?

8 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Extracellular Vesicle.

Who wrote this paper?

Fatemeh Maher, Ali Samadi, Peyman Asadi, Isabella Jodoin.

What is the DOI of this paper?

10.1016/j.vesic.2024.100059. The permanent link is https://doi.org/10.1016/j.vesic.2024.100059.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.